| CD4 count at the time of diagnosis | ||||
Major causes of death (%) | <50 | 50 - 199 | 200 - 349 | 350+ | p-value |
Tuberculosis (n = 102) | 24.5 | 66.7 | 8.8 | 0.0 | .005 |
Multiple infections (n = 34) | 55.9 | 32.4 | 8.8 | 2.9 | |
Wasting syndrome (n = 33) | 48.5 | 36.4 | 15.2 | 0.0 | |
Other specified conditions (n = 19) | 31.6 | 36.8 | 31.6 | 0.0 | |
AIDS related complex (n = 38) | 44.7 | 50.0 | 5.3 | 0.0 | |
Cause unknown (n = 84) | 33.3 | 52.4 | 10.7 | 3.6 | |
Others (n = 51) | 27.5 | 52.9 | 15.7 | 3.9 | |
| WHO clinical stage at the start of ART | ||||
Major causes of death (%) | Stage 1 | Stage 2 | Stage 3 | Stage 4 | p-value |
Tuberculosis (n = 105) | 2.9 | 2.9 | 34.9 | 59.3 | .000 |
Multiple infections (n = 34) | 16.1 | 9.6 | 35.5 | 38.8 | |
Wasting syndrome (n = 34) | 39.3 | 15.1 | 33.4 | 12.2 | |
Other specified conditions (n = 19) | 22.2 | 5.6 | 55.6 | 16.6 | |
AIDS related complex (n = 39) | 25.0 | 11.1 | 36.2 | 27.7 | |
Cause unknown (n = 87) | 11.7 | 7.1 | 31.7 | 49.5 | |
Others (n = 52) | 24.0 | 22.0 | 36.0 | 18.0 | |
| Presence of OIs during treatment | ||||
Major causes of death (%) | Tuberculosis | Candidiasis | Multiple OIs | Others* | p-value |
Tuberculosis (n = 105) | 81.9 | 3.8 | 11.4 | 2.9 | .000 |
Multiple infections (n = 34) | 11.8 | 23.5 | 35.3 | 29.4 | |
Wasting syndrome (n = 34) | 14.7 | 29.4 | 11.8 | 44.1 | |
Other specified conditions (n = 19) | 36.8 | 15.8 | 21.1 | 26.3 | |
AIDS related complex (n = 39) | 17.9 | 33.3 | 10.3 | 38.5 | |
Cause unknown (n = 87) | 34.5 | 20.7 | 12.6 | 32.2 | |
Others (n = 52) | 13.5 | 26.9 | 13.5 | 46.2 | |
| ART adherence during last follow-up | ||||
Major causes of death (%) | Adherence > 95% | Adherence <= 95% | p-value | ||
Tuberculosis (n = 84) | 50.0 | 50.0 | .000 | ||
Multiple infections (n = 32) | 68.7 | 31.3 | |||
Wasting syndrome (n = 34) | 64.7 | 35.3 | |||
Other specified conditions (n = 19) | 63.2 | 36.8 | |||
AIDS related complex (n = 38) | 63.1 | 36.9 | |||
Cause unknown (n = 57) | 49.1 | 50.9 | |||
Others (n = 50) | 64.0 | 36.0 |